|
|
|
|
The MEBO Group, pioneers in the research and application of adult stem cells, was founded by Professor Xu Rong-xiang in 1987. The research has provided the market with innovative technologies and products that fulfills the promise of regeneration and repair, human organs in vivo and in situ. MEBO, is the trademark of MEBO Group. Research on stem cell regeneration in vivo and in situ was conducted on the basis of Moist Exposed Burn Therapy (MEBT), an innovative burn therapy that has been and is currently in worldwide clinical use. With years of basic research, Professor Rongxiang Xu, the inventor of the therapy has identified that it was by skin regeneration and replication from stem cell culturing in situ that MEBT effectively treats burns. It was also confirmed that subsequent to burn injuries, the human body has an instinctive ability to trigger residual tissue in situ to regenerate stem cells, which are then adjusted to give rise to skin tissue. This significant discovery advances human stem cell research into the application of organ regeneration and replication by in vivo and in situ culture of stem cell. Encouraged by the enormous scientific and commercial successes in burned skin regeneration, the MEBO group has been harnessing the power of stem cells for a wide spectrum of clinical applications, which includes, but is not limited to using tissue repair and organ regeneration in the treatment of aged skin, diseased skin, such as diabetic ulcers and baldness, various traumatic wounds, and diseases involving mucous membrane in internal organs such as ulcers. Headquartered in Beijing, the MEBO Group with its international head office in Los Angeles, is delivering valuable pharmaceutical and skin care products to its customers. The primary goals of MEBO group are to satisfy an increasing demand to improve the overall health and wellbeing of every individual. President Subsidiaries Related
Organizations System Structure
|
|
| Copyright 1999-2002 MEBO Group. All rights reserved. |